BACKGROUND: Disease-related prion protein (PrP(Sc)) is readily detectable in lymphoreticular tissues in variant Creutzfeldt-Jakob disease (vCJD), but not in other forms of human prion disease. This distinctive pathogenesis, with the unknown population prevalence of asymptomatic vCJD infection, has led to significant concerns that secondary transmission of vCJD prions will occur through a wide range of surgical procedures. To date PrP(Sc):prion infectivity ratios have not been determined in vCJD, and it is unknown whether vCJD prions are similar to experimental rodent prions, where PrP(Sc) concentration typically reflects infectious prion titre. AIM: To investigate prion infectivity in vCJD tissue containing barely detectable levels of PrP(Sc). METHODS: Transgenic mice expressing only human PrP (Tg(HuPrP129M(+/+)Prnp(o/o))-35 and Tg(HuPrP129M(+/+)Prnp(o/o))-45 mice) were inoculated with brain or rectal tissue from a previously characterised patient with vCJD. These tissues contain the maximum and minimum levels of detectable PrP(Sc) that have been observed in vCJD. RESULTS: Efficient transmission of prion infection was observed in transgenic mice inoculated with vCJD rectal tissue containing PrP(Sc) at a concentration of 10(4.7)-fold lower than that in vCJD brain. CONCLUSIONS: These data confirm the potential risks for secondary transmission of vCJD prions via gastrointestinal procedures and support the use of PrP(Sc) as a quantitative marker of prion infectivity in vCJD tissues.
BACKGROUND: Disease-related prion protein (PrP(Sc)) is readily detectable in lymphoreticular tissues in variant Creutzfeldt-Jakob disease (vCJD), but not in other forms of human prion disease. This distinctive pathogenesis, with the unknown population prevalence of asymptomatic vCJD infection, has led to significant concerns that secondary transmission of vCJD prions will occur through a wide range of surgical procedures. To date PrP(Sc):prion infectivity ratios have not been determined in vCJD, and it is unknown whether vCJD prions are similar to experimental rodent prions, where PrP(Sc) concentration typically reflects infectious prion titre. AIM: To investigate prion infectivity in vCJD tissue containing barely detectable levels of PrP(Sc). METHODS: Transgenic mice expressing only human PrP (Tg(HuPrP129M(+/+)Prnp(o/o))-35 and Tg(HuPrP129M(+/+)Prnp(o/o))-45 mice) were inoculated with brain or rectal tissue from a previously characterised patient with vCJD. These tissues contain the maximum and minimum levels of detectable PrP(Sc) that have been observed in vCJD. RESULTS: Efficient transmission of prion infection was observed in transgenic mice inoculated with vCJD rectal tissue containing PrP(Sc) at a concentration of 10(4.7)-fold lower than that in vCJD brain. CONCLUSIONS: These data confirm the potential risks for secondary transmission of vCJD prions via gastrointestinal procedures and support the use of PrP(Sc) as a quantitative marker of prion infectivity in vCJD tissues.
Authors: A T Axon; U Beilenhoff; M G Bramble; S Ghosh; A Kruse; G E McDonnell; C Neumann; J F Rey; K Spencer Journal: Endoscopy Date: 2001-12 Impact factor: 10.093
Authors: Graham S Jackson; Edward McKintosh; Eckhard Flechsig; Kanella Prodromidou; Petra Hirsch; Jackie Linehan; Sebastian Brandner; Anthony R Clarke; Charles Weissmann; John Collinge Journal: J Gen Virol Date: 2005-03 Impact factor: 3.891
Authors: J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge Journal: Lancet Date: 2001-07-21 Impact factor: 79.321
Authors: E Flechsig; D Shmerling; I Hegyi; A J Raeber; M Fischer; A Cozzio; C von Mering; A Aguzzi; C Weissmann Journal: Neuron Date: 2000-08 Impact factor: 17.173
Authors: Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge Journal: Proc Natl Acad Sci U S A Date: 2008-03-03 Impact factor: 11.205
Authors: Julie Ann Edgeworth; Anita Sicilia; Jackie Linehan; Sebastian Brandner; Graham S Jackson; John Collinge Journal: J Gen Virol Date: 2010-11-17 Impact factor: 3.891
Authors: Malin K Sandberg; Huda Al-Doujaily; Christina J Sigurdson; Markus Glatzel; Catherine O'Malley; Caroline Powell; Emmanuel A Asante; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge Journal: J Gen Virol Date: 2010-07-07 Impact factor: 3.891
Authors: Susan Joiner; Emmanuel A Asante; Jacqueline M Linehan; Lara Brock; Sebastian Brandner; Susan J Bellworthy; Marion M Simmons; James Hope; John Collinge; Jonathan D F Wadsworth Journal: J Neurol Sci Date: 2017-12-29 Impact factor: 3.181
Authors: Elizabeth Kirby; Joanne Dickinson; Matthew Vassey; Mike Dennis; Mark Cornwall; Neil McLeod; Andrew Smith; Philip D Marsh; James T Walker; J Mark Sutton; Neil D H Raven Journal: PLoS One Date: 2012-11-30 Impact factor: 3.240
Authors: Sebastian Brandner; Jerome Whitfield; Ken Boone; Anderson Puwa; Catherine O'Malley; Jacqueline M Linehan; Susan Joiner; Francesco Scaravilli; Ian Calder; Michael P Alpers; Jonathan D F Wadsworth; John Collinge Journal: Philos Trans R Soc Lond B Biol Sci Date: 2008-11-27 Impact factor: 6.237